Vertex Pharma (VRTX): Updating Estimates But No PT Change - Baird

November 29, 2016 6:42 AM EST Send to a Friend
Baird analyst, Brian Skorney, reiterated his Outperform rating on shares of Vertex (NASDAQ: VRTX) after tweaking estimates. Kalydeco and ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login